Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? by Jackson, Caroline & Sudlow, C L M
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is hypertension a more frequent risk factor for deep than for
lobar supratentorial intracerebral haemorrhage?
Citation for published version:
Jackson, CA & Sudlow, CLM 2006, 'Is hypertension a more frequent risk factor for deep than for lobar
supratentorial intracerebral haemorrhage?' Journal of Neurology, Neurosurgery & Psychiatry, vol 77, no. 11,
pp. 1244-1252., 10.1136/jnnp.2006.089292
Digital Object Identifier (DOI):
10.1136/jnnp.2006.089292
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher final version (usually the publisher pdf)
Published In:
Journal of Neurology, Neurosurgery & Psychiatry
Publisher Rights Statement:
Copyright © 2006 BMJ Publishing Group
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
PAPER
Is hypertension a more frequent risk factor for deep
than for lobar supratentorial intracerebral
haemorrhage?
C A Jackson, C L M Sudlow
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:
C A Jackson, Division of
Clinical Neurosciences,
University of Edinburgh,
Western General Hospital,
Bramwell Dott Building,
Edinburgh EH4 2XU, UK;
caroline.jackson@ed.ac.uk
Received 24 January 2006
Revised version received
21 April 2006
Accepted 21 April 2006
Published Online First
11 May 2006
. . . . . . . . . . . . . . . . . . . . . . .
J Neurol Neurosurg Psychiatry 2006;77:1244–1252. doi: 10.1136/jnnp.2006.089292
Objective: To determine whether evidence from observational studies supports the widely held belief that
hypertension is more commonly a risk factor for deep than for lobar supratentorial intracerebral
haemorrhage.
Methods: Studies comparing the frequency of hypertension as a risk factor for deep versus lobar
supratentorial intracerebral haemorrhage, excluding haemorrhages with identified secondary causes,
were identified and subjected to a meta-analysis. The effects of predefined methodological quality criteria
on the results were assessed and other sources of bias were considered.
Results: The pooled result from all 28 included studies (about 4000 patients) found hypertension to be
about twice as common in patients with deep as in those with lobar haemorrhage (odds ratio (OR) 2.10,
95% confidence interval (95% CI) 1.82 to 2.42), but there was significant heterogeneity between studies.
The pooled OR was less extreme for studies that used a pre-stroke definition of hypertension, were
population based or included first-ever strokes only. In the three studies meeting all criteria (601 patients),
deep haemorrhage was associated with a smaller, statistically significant excess of hypertension (OR 1.50,
95% CI 1.09 to 2.07). The OR for studies confined to younger patients seemed to be more extreme (12.32,
95% CI 6.13 to 24.77), but none of these studies fulfilled our methodological quality criteria. Additional,
unquantified sources of bias included uncertainty about whether those doctors reporting brain scans were
blind to hypertension status, uncertain reliability of the classification of haemorrhage location and variable
rates of investigation for secondary causes.
Conclusions: An excess of hypertension was found in patients with deep versus lobar intracerebral
haemorrhages without an identified secondary cause, but this may be due to residual, unquantified
methodological biases.
I
ntracerebral haemorrhage can have several causes. In
younger patients (,40 years), intracranial vascular mal-
formations are the most common single cause of intra-
cerebral haemorrhage, usually lobar in location.1 Cerebral
amyloid angiopathy is thought to underlie about 30% of
intracerebral haemorrhages in those aged .70 years and to
cause mainly lobar haemorrhages.1 Although hypertension is
a major risk factor for intracerebral haemorrhage in general,2–8
it is commonly considered to be associated more with
patients having deep than with those having lobar haemor-
rhage. The current understanding of the arterial pathology
underlying deep haemorrhage is largely based on studies
conducted in the 1960s and 1970s by Fisher and others, with
the meticulous examination and description of brains
examined on autopsy of people with and without an
intracerebral haemorrhage as the cause of their death.9–13
Fisher’s findings led him to propose that hypertensive
lipohyalinosis, affecting the small, deep, perforating, intra-
cranial blood vessels, may lead to lacunar infarction in some
circumstances and to deep intracerebral haemorrhage in
others.11 12 These conclusions, however, were based on small
numbers (his own studies included ,30 patients in total);
the subjects in autopsy studies were sometimes deemed
hypertensive or not on the basis of blood pressure soon after
stroke, and uncertainty remains about whether the vascular
pathology Fisher observed preceded or resulted from haem-
orrhage. Furthermore, lipohyalinotic changes have been
found in the brains of normotensive patients with recent
intracerebral haemorrhage.14 Despite these limitations,
Fisher’s theory of the hypertensive arterial pathology of deep
intracerebral haemorrhage has become so entrenched in the
literature and in clinical teaching and practice15–17 that deep
haemorrhage has become virtually synonymous with hyper-
tensive haemorrhage.
But is hypertension really more commonly a risk factor for
patients with deep haemorrhage than for those with lobar
haemorrhage? In this paper, we report the findings of a
systematic review and meta-analysis of studies that com-
pared the frequency of hypertension as a risk factor for
patients with deep haemorrhage versus those with lobar
supratentorial haemorrhage, and consider the effects of study
methodology on the results.
METHODS
Study identification
We sought studies on patients with intracerebral haemor-
rhage, confirmed after brain imaging or after postmortem
examination, published between January 1966 and December
2004 (inclusive), which provided data on the frequency of
hypertension in patients with deep haemorrhage versus those
with lobar supratentorial intracerebral haemorrhage. We did
not exclude otherwise eligible studies that grouped deep
supratentorial and posterior fossa haemorrhages together, as
the proportion of such studies was small.
We identified studies with a comprehensive electronic
search strategy (see appendix), supplemented by searching
through the reference lists of all relevant articles identified;
our own and colleagues’ collections of papers on intracerebral
haemorrhage; and textbooks on stroke.
See Editorial Commentary, p 1206
1244
www.jnnp.com
Data extraction
We extracted data from included studies on the total number
and source of the patients studied; the numbers with deep or
lobar haemorrhage, before and after any exclusions; the
numbers with hypertension as a risk factor in each of the
groups with deep and lobar haemorrhage; the mean (or
median) age of the patient in each group; the definitions of
deep and lobar haemorrhage and of hypertension; and
whether the study population included first-ever strokes
only. Where possible, to reduce noise in our analyses, we
excluded patients with haemorrhage due to identified
secondary causes unrelated to prior hypertension (such as
intracranial vascular malformation, blood dyscrasia, anti-
coagulant treatment or drug misuse).
As the location of the bleeding source for some large
haemorrhages is unclear from the brain scan, their classifica-
tion as deep or lobar is potentially subject to various sources
of bias. We therefore also extracted any available information
on the type (computed tomography or magnetic resonance
imaging) and timing of diagnostic brain scans; whether any
haemorrhages were considered to be unclassifiable; whether
brain scans were reported blinded to hypertension status;
who reported or reviewed the scans (neuroradiologist,
neurologist, etc); and the intrarater and inter-rater reliability
of the classification of haemorrhage location.
Statistical analyses
We calculated study-specific and summary odds ratios (ORs)
of hypertension in patients with deep versus lobar haemor-
rhage using Cochrane Revman V.4.2.18 We carried out several
sensitivity subgroup analyses, comparing the results from
studies that clearly fulfilled each of several predefined
methodological quality criteria with studies that did not.
These were as follows:
1. A definition of hypertension based solely on raised blood
pressure before stroke (as blood pressure is often raised
after intracerebral haemorrhage, so that blood pressure
after stroke does not necessarily reflect that before
stroke)
2. A population-based study, which we defined as being
either community based or hospital based, where the
hospital was the only centre serving a defined population
and all admissions with intracerebral haemorrhage were
included
3. Inclusion of patients with first-ever stroke only (as risk
factors and the distribution of deep and lobar haemor-
rhage may differ between the first and recurrent strokes).
We then compared results from studies that met all three
methodological quality criteria with those that did not.
In a retrospective subgroup analysis, we compared results
from studies recruiting people unselected for age against
those specifically recruiting younger patients. We used the x2
test to assess statistical heterogeneity between studies and
groups of studies.
RESULTS
Study characteristics
We found 32 potentially relevant studies from a total of 1611
publications identified by our search. From these, we
excluded two studies that reported frequency of hypertension
among patients with recurrent intracerebral haemor-
rhage,19 20 and two from which it was impossible to extract
relevant data.21 22 This left us with 28 studies on a total of
3930 patients (2196 with deep and 1734 with lobar
haemorrhage) for inclusion in our analyses.23–50 Table 1 and
fig 1 summarise the characteristics of these studies.
Lobar haemorrhage was consistently defined as that
occurring in the temporal, parietal, occipital or frontal lobes,
whereas deep haemorrhage was generally defined as that
arising in the basal ganglia region. Two studies reported the
frequency of hypertension for deep supratentorial and
posterior fossa haemorrhages together, and were included
because the proportion of cases with posterior fossa haemor-
rhages was small (eg, 9 posterior fossa v 90 supratentorial
deep haemorrhages in the larger of the two studies).32 49
In all, 7 studies (n = 1352 patients) were population
based,23 25 26 35 40 45 46 13 (n = 1856) used a pre-stroke defini-
tion of hypertension,23 25–27 29 30 36 38–40 45 46 49 4 (n = 614)
included only patients with first-ever stroke25 45 46 50 and only
3 (n = 601) fulfilled all three of these criteria (table 1).25 45 46
Twenty studies reported the mean (or in three studies
median) age, with an overall study size-weighted average
(mean or median) of 59 (range 27–73) years. Fifteen studies
recruited people unselected for age (weighted average
64 years), whereas five specifically recruited a younger
population (generally ,45 years, weighted average 32 years;
fig 1A and table 1). In the eight studies that reported mean or
median age separately for patients with deep and lobar
haemorrhage, patients with deep haemorrhage were slightly
younger than those with lobar haemorrhage (weighted
average 66 v 71 years; table 1).
Six studies23–25 27 41 50 did not exclude people from their
study population with haemorrhages from secondary causes
unrelated to hypertension. The other studies had already
excluded people with haemorrhages from secondary causes
or provided data that allowed us to do so. The proportion of
patients excluded because of a secondary cause was available
from half of the studies.26 28 29 31 33 34 36–39 42–44 47 48 It was highly
variable, ranging from 6% to 73%, and was generally higher
in studies that specifically recruited a younger population
(fig 1B, table 1). Furthermore, in studies that reported on
exclusions from the deep and lobar haemorrhage groups
separately, the proportion excluded was consistently higher—
sometimes substantially so—in the group with lobar hae-
morrhage (table 1). No study reported the proportion of
patients with deep and those with lobar haemorrhage
undergoing further investigation for a secondary cause. But
two studies on younger patients, in which about a third of all
patients underwent catheter angiography, reported that most
patients with hypertension did not have a catheter angio-
gram, especially if their haemorrhage was deep.28 37
Most studies used computed tomography brain imaging,
but only nine reported the time from onset of symptoms to
that of the scan (table 1).23 24 29 33 38–40 45 48 Only a few studies
mentioned any difficulty in classifying the location of the
haemorrhages, and only two actually reported any unclassifi-
able haemorrhages.23 25 No study reported inter-rater or
intrarater reliability of classification of haemorrhage location.
Few studies commented on who reviewed the scans, and
some classified the location based solely on information in
computed tomography scan reports. Only one study reported
that haemorrhage location was classified blind to the
hypertension status of the patient.36
Frequency of hypertension in patients with deep
versus lobar haemorrhage
The pooled OR for all studies suggested that frequency of
hypertension was about twice as common in patients with
deep as in those with lobar haemorrhage (OR 2.10, 95%
confidence interval (CI) 1.82 to 2.42; fig 2). However, we
found statistically significant heterogeneity between indivi-
dual studies (x227 = 75.4; p,0.001), some of which seemed to
be explained by differences in study methods. For each of the
three predefined methodological quality criteria, the sum-
mary OR was substantially lower for studies that fulfilled the
Hypertension and supratentorial intracerebral haemorrhage 1245
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Table 1 Characteristics of studies
Total (deep/lobar)
Study*
Year of
publication Study population
Methodological
quality criteria
fulfilled
Exclusions due to
secondary causes
% of patient
excluded
Number of
patients in
analyses
Mean or
median age
Time to
scan
Studies of populations unselected for age
New Orleans,
USA48
1979 Consecutive
admissions to the
neurology
department
— AVM, blood dyscrasia,
coagulopathy or
on anticoagulants
9% (3%/41%) 242 (222/20) NR Within
8 days
Heidelberg,
Germany34
1982 Non-consecutive
admissions to hospital
— AVM, CVT, or on
anticoagulants
19% (2%/37%) 71 (44/27) 58 (NR) NR
Copenhagen,
Denmark33
1984 Non-consecutive
admissions to
neurology and
neurosurgery departments
— AVM, on
anticoagulants, alcohol
misuse
25% (0%/41%) 36 (19/17) 54** (NR) Median
2 days
Cincinnati (a),
USA27
1986 Retrospective review
of admissions to 16
general hospitals
BP-pre None 0% 124 (51/73) NR NR
New York,
USA38
1987 Consecutive admissions
to one hospital in the
Bronx area of the city
BP-pre Blood dyscrasia,
vasculitis or AVM
18% (11%/29%) 92 (62/30) NR Within
24 h of
admission
Rome, Italy29 1988 Admissions to one
city-centre hospital
BP-pre AVM or on
anticoagulants
6% (NR) 87 (56/31) 62 (NR) Mean
1.6 days
Florence,
Italy36
1990 Non-consecutive
patients identified
from the neuroradiology
service
BP-pre Blood dyscrasia,
on anticoagulants,
or AVM
31% (24%/48%) 70 (54/16) 63 (NR) NR
Giessen,
Germany44
1990 Admissions to
neurology department
of one hospital
— AVM,
haemorrhagic diathesis,
or on warfarin
13% (8%/15%) 79 (57/22) 66** (NR) NR
Linkoping,
Sweden41
1991 Consecutive admissions
to neurology
department
— None 0% 182 (102/80) 65 (NR) NR
Riyadh,
Saudi
Arabia50
1991 Admissions to hospital FES, BP-pre NR NR 13 (10/3) 49 (51/43) NR
USA39 1991 Admissions to hospitals
(multicentre involving
4 different cities)
— AVM,
coagulopathy,
ventricular
haemorrhage, multiple
haemorrhages or
on anticoagulants
17% (NR) 172 (107/65) 62** (59/68) Mean
1 day
Cincinnati
(b), USA26
1993 Review of medical records
from 20
acute-care hospitals
and 5 coroner’s
offices
P, BP-pre Haemorrhagic
infarction, AVM,
anticoagulants,
thrombolytic treatment,
cocaine use
11% (NR) 143 (77/66) NR NR
Oxford, UK25 1993 Community-based
(overlapping sources used
to identify cases occurring
in a
defined area)
P, FES, BP-pre None 0% 42 (18/24) 71 (67/72) NR
Durham,
USA30
1994 Consecutive
admissions to one hospital
BP-pre Thrombocytopenia,
inherited coagulopathy,
or AVM
NR 45 (29/16) 61 (56/67) NR
Essen,
Germany24
1994 Admissions to
hospital
— None 0% 300 (46/254) NR Within
24 h of
admission
Perth,
Australia23
1994 Community-based
(overlapping sources used
to identify cases occurring
in a
defined area)
P, BP-pre None 0% 37 (18/19) 68 (NR) Median
4 days
Massachusetts,
USA32
1996 Consecutive patients
aged .50 years with lobar
haemorrhage,
and with non-lobar
haemorrhage. Unclear
if both groups were
recruited from same
place and during the same
time period
— AVM, vasculitis or
coagulopathy
NR 63 (18/45) 73 (69/75) NR
Cologne,
Germany42
1997 Retrospective review
of admissions to two
hospitals
— Haemorrhagic infarcts,
AVM, cavernoma,
coagulation
disorders, on
thrombolytic or
anticoagulation therapy
23% (10%/33%) 575 (278/297) 57 (NR) NR
1246 Jackson, Sudlow
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Total (deep/lobar)
Study*
Year of
publication Study population
Methodological
quality criteria
fulfilled
Exclusions due to
secondary causes
% of patient
excluded
Number of
patients in
analyses
Mean or
median age
Time to
scan
Victoria,
Australia46
1998 Consecutive admissions
to all hospitals serving
a defined population
and regular inspection
of coroner’s reports
P, FES, BP-pre AVM, haemorrhagic
transformation,
bleeding diathesis
or drug misuse
NR 264 (122/142) 64 (NR) NR
Besanc¸on,
France45
2000 Consecutive admissions
to neurology, neurosurgery
or intensive care units
of the only hospital in
the county to which patients
with neurological diseases
are referred
P, FES, BP-pre Haemorrhagic
infarction, AVM,
cavernoma or on
thrombolytic treatment,
NR 295 (167/128) 67 (NR) Mean
1 day
Sweden40 2000 Community-based
(12 hospitals and four
pathology departments
serving a defined
population)
P AVM,
haemorrhagic infarction
NR 297 (121/176) 74** (72/75) 1–2 days
Cincinnati (c),
USA49
2002 Non consecutive
patients, identified by
surveillance of
emergency and
radiology departments,
and hospital discharge
diagnoses
BP-pre Haemorrhagic
infarction, AVM or
cavernoma
NR 188 (121/67) 65 (65/65) NR
Izumo, Japan35 2003 Admissions to the four
hospitals in the city,
and review of general
practitioner death
certificates
P AVM, moyamoya
disease
haemorrhagic
infarction or
coagulation disorder
NR 274 (229/45) 68 (68/71) NR
Studies in younger patient populations
Iowa, USA47 1987 Patients aged 15–45
years admitted to
hospital
— AVM, haemorrhage
as a result of drug
or alcohol misuse,
SLE, moyamoya,
cryoglobulinaemia,
or preeclampsia
58% (41%/67%) 22 (10/12) 31 (NR) NR
Dijon, France31 1991 Patients aged ,45
years admitted to
neurosurgery,
neurology and
rehabilitation departments
of the
city’s university
hospital
— AVM, cerebral
vein thrombosis,
SLE, endocarditis,
leukaemia or on
anticoagulants
59% (27%/76%) 12 (8/5) 33 (NR) NR
Mexico City,
Mexico43
1991 Consecutive admission
of patients aged ,40 years
to stroke
unit
— AVM, cavernous
angioma, CVT, drug
use, toxaemia or
other known causes
75% (49%/85%) 38 (22/16) 27 (NR) NR
Tainan Taiwan
(a)37
1997 Patients aged 14–40 years
admitted to hospital
— AVM, drug misuse,
blood dyscrasia,
alcohol misuse, SLE,
moyamoya or
infective endocarditis
35% (24%/50%) 40 (26/14) 34 (NR) NR
Kaohsiung,
Taiwan (b)28
1999 Patients aged 15–44 years
admitted to hospital
— AVM, blood
dyscrasia and
‘‘other rare causes’’
(including alcohol
and drug misuse,
uraemia, etc). We could
not exclude 4 patients
with tumours.
33% (12%/53%) 126 (102/24) 36 (NR) NR
AVM, arteriovenous malformation; CVT, cerebral venous thrombosis; NR, not reported; SLE, systemic lupus erythematosus.
*Studies are ordered first according to whether they included mixed-age or younger populations, and then by year of publication.
; BP-pre, definition of hypertension based on pre-stroke blood pressure (not post-stroke or combination of pre-stroke and post-stroke blood pressure); FES, first-
ever stroke only; P, population based.
`Percentage of all deep and lobar supratentorial haemorrhages excluded because of secondary causes (except for Rome, Cincinnati (b) and USA, where the
percentage excluded is calculated with all haemorrhages, including those in the posterior fossa, as the denominator).
1A total of 3930 patients with haemorrhage were included in the analyses, 2196 of whom had a deep haemorrhage.
Mean or median (indicated by **) age of total population with intracerebral haemorrhage (including those with posterior fossa haemorrhage). In cases where
age was reported as the number of patients within various age bands, mean age was derived by assigning the middle value of each age band to the number of
patients included.
Table 1 Continued
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criterion than for those that did not, with significant
heterogeneity between the two groups of studies in each
case (fig 3). The pooled OR for the three studies (601
patients) meeting all three criteria (OR 1.50, 95% CI 1.09 to
2.07) suggested a smaller but still statistically significant
excess of hypertension in deep versus lobar haemorrhage.
The OR for these methodologically more rigorous studies was
substantially lower than that for the remaining studies (OR
2.27, 95% CI 1.94 to 2.66), with significant heterogeneity
between the two groups (fig 3).
The pooled OR for studies that included only younger
patients (OR 12.32, 95% CI 6.13 to 24.77) was far larger than
for studies that recruited a population unselected for age (OR
1.91, 95% CI 1.65 to 2.21).
DISCUSSION
The pooled result from all the studies we analysed suggested
that hypertension was twice as common a risk factor for
patients with deep haemorrhage than with lobar haem-
orrhage without an identified secondary cause. We found an
excess of hypertension among patients with deep haemor-
rhage in the methodologically more rigorous studies, albeit
smaller and statistically less certain. As only three studies
actually met all of our rather modest criteria for methodo-
logical quality, this summary estimate is based on quite small
numbers of patients (601, less than one sixth of the total in
all studies included). The differences between subgroups in
the various sensitivity analyses are striking and emphasise
the effect of study methods on the results.
We could not quantify the effect of the additional potential
sources of bias that we considered, but these are also likely to
have affected the results. Firstly, some misclassification of
haemorrhage location must surely have occurred, yet only two
studies acknowledged this, none reported reliability of the
classification of the haemorrhage location and only one
mentioned that scans were reported blind to hypertension
status. As the concept of deep hypertensive haemorrhage is
entrenched in clinical teaching and practice, the knowledge of
a patient’s hypertension status may have influenced the
classification of haemorrhage location and may have generated
a spurious association between hypertension and deep versus
lobar haemorrhage. This may be particularly true in the
classification of large haemorrhages, for which the location of
the original bleeding source may be uncertain. Many such
corticosubcortical haemorrhages are thought to originate from
the basal ganglia, but evidence for this is limited.15
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Figure 1 (A) Mean or median age of study populations. (B) Proportion of patients excluded because of haemorrhage from a secondary cause, such as
intracranial vascular malformation, blood dyscrasia or anticoagulant treatment.
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Secondly, few studies reported on the timing of the brain
scan relative to the onset of symptoms. Many may have
included some patients with haemorrhagic transformation of
a cerebral infarct, although it is difficult to know just how
this may have affected our results.
Thirdly, investigation bias is likely to have affected the
results of these studies to a variable degree. The study
populations included in our analyses depended on the extent
of patient investigation, which may well have differed
between groups with deep and lobar haemorrhage and
according to age. The available data showed a larger
proportion of exclusions from younger study populations
than from those unselected for age, and from groups of
patients with lobar rather than deep haemorrhage. This could
be because of real differences in the proportions with an
underlying secondary cause, higher rates of investigation on
New Orleans
Heidelberg
Copenhagen
Cincinnati (a)
New York
Cincinnati (c)
Rome
Florence
Giess en
Linkoping
Riyadh
USA
Cincinnati (b)
Oxford
Durham
Essen
Perth
Massachusetts
Cologne
Victoria
Besancon
Sweden
Izumo
Iowa
Dijon
Taiwan (a )
Taiwan (b )
Total
187/ 222
33/44
9 / 19
24/ 51
47/ 62
89/ 121
39/ 56
32/ 54
47/ 57
42/ 102
8/ 10
86/ 107
56/ 77
10/ 18
25/ 29
11/ 18
26/ 46
15/ 18
216/ 278
65/ 122
103/ 167
46/ 121
186/ 229
6/ 10
8/ 8
20/ 26
83/ 102
8/ 20
18/ 27
5/ 17
30/ 73
20/ 30
30/ 67
16/ 31
4/ 16
8/ 22
37/ 80
0/ 3
36/ 65
44/ 66
11/ 24
11/ 16
102/ 254
11/ 19
29/ 45
178/ 297
71/ 142
58/ 128
60/ 176
26/ 45
4/ 12
1/ 5
1/ 14
7/ 24
1535/ 2196 828/ 1734
Mexico 16/ 22 2/ 16
OR
OR
95% CI
Deep
(n/N)
Lobar
(n/N)S tudy
0.1 1 10 100
2.10 (1.82 to 2.42)
Figure 2 Odds ratios (ORs) for hypertension in patients with deep versus lobar haemorrhage. The OR for each study is shown as a square, its size
denoting the statistical weight of the study. Horizontal lines represent 95% confidence intervals (CIs). The diamond represents the pooled OR, with the
95% CI represented by the width of the diamond. Studies are ordered first according to whether they included mixed-age or younger populations, and
then by year of publication. N, total number of patients; n, number of patients with hypertension. Heterogeneity between studies: x227 = 75.44;
p,0.001.
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younger patients and on those with lobar haemorrhage, or
both. Some support for differential investigation bias being
part of the explanation comes from two studies on younger
patients that reported lower rates of catheter angiography
among patients with hypertension and deep haemorrhage,28 37
as well as from the (admittedly anecdotal) observation that, in
clinical practice, a non-hypertensive structural cause is less
often considered and sought if a history of hypertension and
brain imaging shows a deep rather than a lobar haemorrhage.
Some of the excess of hypertension found among patients with
deep haemorrhage may therefore be accounted for by differ-
ential investigation, resulting in secondary causes remaining
undetected among those having deep haemorrhage with
coincidental hypertension.
We may expect studies on younger patients to be particularly
useful in that these patients should be more extensively
investigated and thus allow a more accurate assessment of the
contribution of hypertension to deep and lobar haemorrhages
that have no identifiable secondary cause. We found that the
frequency of hypertension in patients with deep versus lobar
haemorrhage was much higher in studies on only young
patients than in those studies that did not select on age. This
result, however, is difficult to interpret, as the number of
patients included in the studies on younger patients (n = 238)
was very small, making the results imprecise. Furthermore,
none of these studies met any of our predefined methodological
quality criteria, and the result could reflect greater investigation
bias in younger patients. None the less, the apparently more
extreme excess of hypertension in younger patients with deep
versus lobar haemorrhages is an interesting finding that
deserves further study.
Given that cerebral amyloid angiopathy is thought to be
particularly important in elderly people, it would have been
interesting to assess the effect of age on the results of studies in
which patients were unselected for age. Only two studies,
however, reported a frequency of hypertension by age group;
they used different age cut-offs andthenumbers of patients were
too small to allow any meaningful analyses. This is a limitation of
our systematic review and further large studies that allow age-
specific analyses are required to explore this issue.
Our analyses have considered the contribution of chroni-
cally raised blood pressure to lobar and deep haemorrhage.
Intracerebral haemorrhage may also arise as a result of
acutely raised blood pressure, particularly in previously
normotensive people. Such acute sudden rises in blood
pressure may be of more importance for deep than for lobar
haemorrhage, but this would be particularly difficult to study
in humans, because it is impossible to distinguish raised
blood pressure arising as a result of the intracerebral
haemorrhage from sudden raised blood pressure precipitating
the haemorrhage. Although there are reports in the literature
of instances where intracerebral haemorrhage was assumed
Heterogeneity   between two groups:χ2 (1) = 4.72; p = 0.03
Heterogeneity   between two groups:χ2 (1) = 4.02; p = 0.05 
Heterogeneity   between two groups:χ2 (1) = 11.22; p = 0.0008 
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Figure 3 Sensitivity subgroup analyses using pre-defined methodological quality criteria. The black diamonds represent the summary odds ratios
(ORs) for studies meeting each criterion, the white diamonds represent the summary ORs for studies not meeting each criterion and the grey diamond
represents the pooled OR for all 28 studies. CI, confidence interval.
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to be the result of acutely raised blood pressure, no clear
evidence indicates that this occurs more often in patients
with deep than with lobar haemorrhage.1 51
In summary, pooled results from observational studies
suggest that hypertension is more frequently a risk factor for
deep than for lobar haemorrhage, perhaps particularly in
younger age groups. These findings are, however, heavily
influenced by studies with less robust methods. In the
methodologically more rigorous studies, we found a smaller,
but still statistically significant, excess of hypertension
among patients with deep haemorrhage. This may, however,
be accounted for by additional, unquantified sources of bias.
Further large, methodologically robust studies are needed to
determine accurately the relative contribution of hyperten-
sion to deep and lobar haemorrhage in different age groups.
After the exclusion of secondary causes, raised blood pressure
may make an important contribution to the arterial
pathologies underlying lobar haemorrhages—for example,
cerebral amyloid angiopathy—as well as to those leading to
rupture of small, deep, penetrating arteries. Thus, the terms
hypertensive haemorrhage and deep haemorrhage should not
be considered synonymous, as this implies that all deep
haemorrhages are attributable solely to hypertension. This
may cause some patients with deep haemorrhages routinely
to be excluded from further investigation on potentially
treatable non-hypertensive causes (such as arteriovenous
malformations), especially if they are elderly.
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APPENDIX
Medline search
1. exp intracranial hemorrhages/
2. ((brain$ or cerebral or intracranial or intracerebral) adj5
(haemorrhage$ or hemorrhage$ or bleed$)).tw.
3. ich.tw.
4. exp intracranial hemorrhages/ or ((brain$ or cerebral or
intracranial or intracerebral) adj5 (haemorrhage$ or
hemorrhage$ or bleed$)).tw. or ich.tw
5. (lobar or deep or subcortical or sub-cortical).tw.
6. exp cerebral amyloid angiopathy/
7. cerebral amyloid angiopath$.tw.
8. exp cerebral amyloid angiopathy/ or cerebral amyloid
angiopath$.tw.
9. (lobar or deep or subcortical or sub-cortical).tw. or exp
cerebral amyloid angiopathy/ or cerebral amyloid angio-
path$.tw.
10. exp intracranial hemorrhages/ or ((brain$ or cerebral or
intracranial or intracerebral) adj5 (haemorrhage$ or
hemorrhage$ or bleed$)).tw. or ich.tw and (lobar or deep
or subcortical or sub-cortical).tw. or exp cerebral
amyloid angiopathy/ or cerebral amyloid angiopath$.tw.
A similar search was used for Embase.
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